BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21285383)

  • 21. P-selectin expression in canine cutaneous inflammatory diseases and mast cell tumors.
    Chénier S; Doré M
    Vet Pathol; 1998 Mar; 35(2):85-93. PubMed ID: 9539361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical detection of retinoid receptors in tumors from 30 dogs diagnosed with cutaneous lymphoma.
    de Mello Souza CH; Valli VE; Selting KA; Kiupel M; Kitchell BE
    J Vet Intern Med; 2010; 24(5):1112-7. PubMed ID: 20707846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E-cadherin and beta-catenin reduction influence invasion but not proliferation and survival in canine malignant mammary tumors.
    Brunetti B; Sarli G; Preziosi R; Monari I; Benazzi C
    Vet Pathol; 2005 Nov; 42(6):781-7. PubMed ID: 16301574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of proto-oncogene C-kit and correlation with morphological evaluations in canine cutaneous mast cell tumors.
    Passantino L; Passantino G; Cianciotta A; Ribaud MR; Lo Presti G; Ranieri G; Perillo A
    Immunopharmacol Immunotoxicol; 2008; 30(3):609-21. PubMed ID: 18608529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TSLC1 tumour-suppressor gene expression in canine mast cell tumours.
    Taylor F; Murphy S; Hoather T; Dobson J; Scase T
    Vet Comp Oncol; 2010 Dec; 8(4):263-72. PubMed ID: 21062408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PCR-based clonality analysis of antigen receptor gene rearrangements in canine cutaneous plasmacytoma.
    Takanosu M; Okada K; Kagawa Y
    Vet J; 2018 Nov; 241():31-37. PubMed ID: 30340657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of histiocytic diseases of dogs and cats.
    Moore PF
    Vet Pathol; 2014 Jan; 51(1):167-84. PubMed ID: 24395976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization of cytoplasmic lysozyme immunoreactivity as a histiocytic marker in canine histiocytic disorders.
    Moore PF
    Vet Pathol; 1986 Nov; 23(6):757-62. PubMed ID: 3027941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canine histiocytic diseases.
    Coomer AR; Liptak JM
    Compend Contin Educ Vet; 2008 Apr; 30(4):202-4, 208-16; quiz 216-17. PubMed ID: 18576276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two canine Merkel cell tumours: immunoexpression of c-KIT, E-cadherin, beta-catenin and S100 protein.
    Gil da Costa RM; Rema A; Pires MA; Gärtner F
    Vet Dermatol; 2010 Apr; 21(2):198-201. PubMed ID: 19706008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical expression of ionized calcium binding adapter molecule 1 in cutaneous histiocytic proliferative, neoplastic and inflammatory disorders of dogs and cats.
    Pierezan F; Mansell J; Ambrus A; Rodrigues Hoffmann A
    J Comp Pathol; 2014 Nov; 151(4):347-51. PubMed ID: 25172051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneously regressive canine cutaneous histiocytoma: a counterpart of human regressing atypical histiocytosis?
    Yang TJ
    Anticancer Res; 1987; 7(4B):811-2. PubMed ID: 2823685
    [No Abstract]   [Full Text] [Related]  

  • 33. Cutaneous histiocytic sarcoma with E-cadherin expression in a Pembroke Welsh Corgi dog.
    Hirako A; Sugiyama A; Sakurai M; Ozaki K; Sakai H; Takeuchi T; Morita T; Moore PF
    J Vet Diagn Invest; 2015 Sep; 27(5):589-95. PubMed ID: 26330395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of cell adhesion molecules and doublecortin in canine anaplastic meningiomas.
    Ide T; Uchida K; Suzuki K; Kagawa Y; Nakayama H
    Vet Pathol; 2011 Jan; 48(1):292-301. PubMed ID: 21123860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple, resolving, cutaneous histiocytoma in a dog.
    Bender WM; Muller GH
    J Am Vet Med Assoc; 1989 Feb; 194(4):535-7. PubMed ID: 2537810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E-cadherin expression in canine cutaneous histiocytoma.
    Pires I; Alves A; Rodrigues P; Queiroga FL; Lopes CS
    Vet Rec; 2008 Jul; 163(2):59-60; author reply 60. PubMed ID: 18622005
    [No Abstract]   [Full Text] [Related]  

  • 37. Canine gastrointestinal stromal tumors: immunohistochemical expression of CD34 and examination of prognostic indicators including proliferation markers Ki67 and AgNOR.
    Gillespie V; Baer K; Farrelly J; Craft D; Luong R
    Vet Pathol; 2011 Jan; 48(1):283-91. PubMed ID: 20826846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous plasmacytomas in dogs: a morphologic and immunohistochemical study.
    Baer KE; Patnaik AK; Gilbertson SR; Hurvitz AI
    Vet Pathol; 1989 May; 26(3):216-21. PubMed ID: 2669312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ki67/KIT double immunohistochemical staining in cutaneous mast cell tumors from Boxer dogs.
    Fonseca-Alves CE; Bento DD; Torres-Neto R; Werner J; Kitchell B; Laufer-Amorim R
    Res Vet Sci; 2015 Oct; 102():122-6. PubMed ID: 26412531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous mast cell tumour within a lipoma in a boxer.
    Jakab C; Szász AM; Kulka J; Schaff Z; Rusvai M; Németh T; Gálfi P
    Acta Vet Hung; 2009 Jun; 57(2):263-74. PubMed ID: 19584039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.